{
    "nctId": "NCT06001528",
    "briefTitle": "Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer",
    "officialTitle": "Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Lymph Node Metastasis",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2400,
    "primaryOutcomeMeasure": "Metabolic difference detection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Pathological diagnosis of breast cancer\n* No preoperative therapy including chemotherapy or endocrine therapy\n* No distant metastasis\n* Underwent mastectomy or breast-conserving surgery with sentinel lymph node biopsy\n* Agreed to provide preoperative peripheral blood samples\n* Had access to imaging, pathological and follow-up data for preoperative and postoperative evaluation of the disease\n\nExclusion Criteria:\n\n* Neoadjuvant therapy\n* Presence of distant metastasis at time of diagnosis\n* Primary malignancies other than breast cancer\n* Bilateral breast cancer or previous contralateral breast cancer\n* Undergo modified radical surgery for breast cancer without sentinel lymph node biopsy\n* Incomplete pathological data and follow-up data\n* Pregnancy and other conditions determined by the investigator to be ineligible for inclusion in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}